Science Explorer Back to mapMap
Discussion
Researcher · Inserm · France

Alexandre Loupy

Alexandre Loupy publishes mostly in Transplantation, Surgery and Nephrology, on topics such as Renal Transplantation Outcomes and Treatments, Transplantation: Methods and Outcomes and Organ Transplantation Techniques and Outcomes.

ORCID 0000-0003-3388-7747 OpenAlex
World rank
#63,542
of 7,710,434 ranked researchers
Rank in France
#6,156
of 324,115
Works
400
Citations
20k
Citations per work
49.6
h-index
66
i10-index 159Top 1.3% in Transplantation
Alexandre Loupy

What does Alexandre Loupy research?

Alexandre Loupy's work is mostly in Medicine (68%), Immunology and Microbiology (5%).

Health Sciences: 271 works · 67.8% of their workMedicine: 271 works · 67.8% of their workTransplantation: 100 works · 25.0% of their workSurgery: 92 works · 23.1% of their workNephrology: 30 works · 7.6% of their workPulmonary and Respiratory Medicine: 24 works · 6.1% of their workPublic Health, Environmental and Occupational Health: 24 works · 6.0% of their workEverything else: 110 works · 27.4% of their workLife Sciences: 19 works · 4.8% of their workImmunology and Microbiology: 19 works · 4.8% of their workImmunology: 19 works · 4.8% of their workTHEIR WORKAlexandre Loupy400works
Life Sciences5%Health Sciences68%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine27167.8%
  2. Everything else11027.4%
    1. Immunology and Microbiology194.8%
  1. 1Transplantation25% of their works
  2. 2Surgery23% of their works
  3. 3Nephrology8% of their works
  4. 4Pulmonary and Respiratory Medicine6% of their works
  5. 5Public Health, Environmental and Occupational Health6% of their works
  6. 6Immunology5% of their works

Research topics

Which keywords describe Alexandre Loupy's research?

The keywords of their largest research topics: Graft Survival, Kidney Transplantation, Immunosuppressive Drugs, Renal Allograft, Transplantation, Immunosuppressive Therapy, Lung Transplant and Rejection.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 20 words, with their numbers
  1. Graft Survival3262 topics
  2. Kidney Transplantation3172 topics
  3. Immunosuppressive Drugs2611 topic
  4. Renal Allograft2611 topic
  5. Transplantation1942 topics
  6. Immunosuppressive Therapy1752 topics
  7. Lung Transplant1381 topic
  8. Rejection1381 topic
  9. Ischemia-Reperfusion Injury651 topic
  10. Liver Transplantation651 topic
  11. Fibromuscular Dysplasia571 topic
  12. Glomerular Diseases571 topic
  13. Nephrotic Syndrome571 topic
  14. Renal Artery Stenosis571 topic
  15. Living Kidney Donors561 topic
  16. Organ Donation561 topic
  17. Myocarditis371 topic
  18. Viral Infection371 topic
  19. Complement291 topic
  20. Immune291 topic

Where does Alexandre Loupy work?

Alexandre Loupy's main affiliation in the publication record is Inserm, France.

How many publications and citations does Alexandre Loupy have?

OpenAlex counts 400 works and 19,838 citations for Alexandre Loupy, an h-index of 66, ranking #63,542 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Alexandre Loupy. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.